Financial Year |
March 31 2023 |
Monetary Funds |
909,714,774.20 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
3,142,461.68 |
Accounts Receivable |
653,689,319.44 |
Advances to Suppliers |
99,777,884.52 |
Other Receivables |
110,500,306.40 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
784,940,181.34 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
18,730,265.95 |
Total Current Assets |
2,580,495,969.05 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
23,217,664.33 |
Investment Properties |
57,585,806.82 |
Fixed Assetes |
352,728,578.98 |
Under-construction Projects |
322,598,405.72 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
59,577,432.58 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
159,605,803.19 |
Deferred Income Tax Assets |
718,551.39 |
Other Non-Current Assets |
13,035,809.38 |
Sub-Total of Non-Current Assets |
1,563,444,355.28 |
Total Assets |
4,143,940,324.33 |
Short-Term Loans |
60,070,583.34 |
Trading Financial liabilities |
-- |
Notes Payable |
186,304,929.01 |
Accounts Payable |
767,234,715.02 |
Accounts Received In Advance |
2,313,032.73 |
Employee Compensation Payable |
44,019,441.24 |
Taxes Payable |
4,523,599.21 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
93,602,469.09 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
23,894,188.96 |
Other Current Liabilities |
8,554,238.25 |
Sub-Total of Current Liabilities |
1,409,263,238.72 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
258,667,048.91 |
Total Liabilities |
1,667,930,287.63 |
Paid-In Capital(Or Share Stock) |
550,914,700.00 |
Capital Surplus |
524,915,230.47 |
Surplus Reserve |
227,434,854.79 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,141,048,642.76 |
Minority Stockholder's Interest |
34,428,575.11 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,441,581,461.59 |
Owner's Equity(Stockholder's Equity) |
2,476,010,036.70 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
4,143,940,324.33 |